7-Hydroxy-4-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 250mg

2-(tert-Butoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 1g

2-(Chloromethyl)-6-methoxy-3-(trifluoromethyl)pyridine, 97.0%, 250mg

3-(Trifluoromethyl)phenylacetone>98.0%(GC)25g

5-Nitrothiophene-3-carboxylic acid, 98.0%, 10g

3-Phenylbutyraldehyde, 95.0%, 1g

Ethyl 4,6-dihydroxypyridazine-3-carboxylate, 95.0%, 1g

1-Bromo-2-chloro-3,6-difluorobenzene, 95.0%, 5g

BMPyrr TFSI, 100 g, >=99%, glass packaging

4-(2H-Benzo[d][1,2,3]triazol-2-yl)butanoic acid, 97%, 250mg

1-(tert-Butyl) 3-ethyl 4-amino-5,6-dihydropyridine-1,3(2H)-dicarboxylate, 97%, 5g

(2-Methyl-1-benzofuran-5-yl)amine, 95.0%, 1g

(S)-5'-Bromospiro[imidazolidine-4,1'-indene]-2,3',5(2'H)-trione, 97%, 250mg